Tu, Z., Wang, C., Hu, Q., Tao, C., Fang, Z., Lin, L., . . . Zhu, X. (2023, March). Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy. Journal of Experimental & Clinical Cancer Research.
芝加哥风格引文Tu, Zewei, et al. "Protein Disulfide-isomerase A4 Confers Glioblastoma Angiogenesis Promotion Capacity and Resistance to Anti-angiogenic Therapy." Journal of Experimental & Clinical Cancer Research Mar. 2023.
MLA引文Tu, Zewei, et al. "Protein Disulfide-isomerase A4 Confers Glioblastoma Angiogenesis Promotion Capacity and Resistance to Anti-angiogenic Therapy." Journal of Experimental & Clinical Cancer Research, Mar. 2023.
警告：这些引文格式不一定是100％准确.